Skip to main content

Guidance and regulation

Skip to results

185 results

Skip to results
185 results sorted by Most viewed
From Veterinary Medicines Directorate (VMD)
  • MAVIS hub edition 129

    Marketing Authorisations Information Service (MAVIS) Hub edition 129

    • From: Veterinary Medicines Directorate
    • Updated:
  • MAVIS Newsletter edition 108

    Marketing Authorisations Veterinary Information Service (MAVIS) edition 108

    • From: Veterinary Medicines Directorate
    • Updated:
  • MAVIS Hub Edition 116

    Marketing Authorisations Information Service (MAVIS) Hub edition 116

    • From: Veterinary Medicines Directorate
    • Updated:
  • Supply Issues

    Notification to the VMD if they have a reason to suspect, or know of, a threat to the continued supply of a veterinary medicine.

    • From: Veterinary Medicines Directorate
    • Updated:
  • Mavis Hub Edition 125

    Marketing Authorisations Information Service (MAVIS) Hub edition 125.

    • From: Veterinary Medicines Directorate
    • Updated:
  • Mavis Hub Edition 126

    Marketing Authorisations Information Service (MAVIS) Hub edition 126.

    • From: Veterinary Medicines Directorate
    • Updated:
  • Published standards for regulatory work 2022-2023

    VMD Published Standards for regulatory work 2022-2023.

    • From: Veterinary Medicines Directorate
    • Updated:
  • MAVIS Hub Edition 117

    Marketing Authorisations Information Service (MAVIS) Hub edition 117

    • From: Veterinary Medicines Directorate
    • Updated:
  • Mavis Hub Edition 124

    Marketing Authorisations Information Service (MAVIS) Hub edition 124.

    • From: Veterinary Medicines Directorate
    • Updated:
  • MAVIS Hub Edition 120

    Marketing Authorisations Information Service (MAVIS) Hub edition 120

    • From: Veterinary Medicines Directorate
    • Updated:
  • Published standards for regulatory work 2024/2025

    These published standards relate to a number of KPIs in the VMD Deliverables and KPI document.

    • From: Veterinary Medicines Directorate
    • Updated:
  • Response to identification of resistant bacterial isolate: Contingency plan

    Lines of communication and action to be taken including the Government departments and agencies responsible.

    • From: Veterinary Medicines Directorate
    • Updated:
  • MAVIS Hub Edition 130

    Marketing Authorisations Information Service (MAVIS) Hub edition 130

    • From: Veterinary Medicines Directorate
    • Updated:
  • VMD Corporate Priorities: 2023 – 2024

    Details of the VMD Corporate Priorities for 2023 – 2024.

    • From: Veterinary Medicines Directorate
    • Updated:
  • MAVIS Hub Edition 132

    Marketing Authorisations Veterinary Information Service (MAVIS) Hub edition 132.

    • From: Veterinary Medicines Directorate
    • Updated:
  • MAVIS Newsletter edition 105

    Marketing Authorisations Veterinary Information Service (MAVIS) edition 105

    • From: Veterinary Medicines Directorate
    • Updated:
  • Mavis Hub Edition 122

    Marketing Authorisations Information Service (MAVIS) Hub edition 122.

    • From: Veterinary Medicines Directorate
    • Updated:
  • MAVIS Hub Edition 118

    Marketing Authorisations Information Service (MAVIS) Hub edition 118

    • From: Veterinary Medicines Directorate
    • Updated:
  • MAVIS Hub Edition 131

    Marketing Authorisations Information Service (MAVIS) Hub edition 131

    • From: Veterinary Medicines Directorate
    • Updated:
  • United Kingdom-Canada Regulatory Cooperation: Guidance on Veterinary Drug Simultaneous Reviews

    The process for the simultaneous review of veterinary drug submissions by Health Canada’s Veterinary Drugs Directorate and the UK's Veterinary Medicines Directorate.

    • From: Veterinary Medicines Directorate
    • Updated: